![Results from Qu Biologics' Crohn's Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021 - Life Sciences British Columbia Results from Qu Biologics' Crohn's Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021 - Life Sciences British Columbia](https://lifesciencesbc.ca/wp-content/uploads/2021/06/Qu-Biologics_logo-303x194.png)
Results from Qu Biologics' Crohn's Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021 - Life Sciences British Columbia
![14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/e63342e3c9fd510184d2343b4232c16550758458/MASTER_ECCO%2719%20Web%20banner_150x100%20%28002%29.jpg)
14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![Systemic molecular mediators of inflammation differentiate Between crohn's disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy Systemic molecular mediators of inflammation differentiate Between crohn's disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy](https://s3-eu-west-1.amazonaws.com/figshare-production-eu-ul-previews6775-eu-west-1/35232724/thumb.png)
Systemic molecular mediators of inflammation differentiate Between crohn's disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy
![Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG‐IBD study - Dragoni - 2023 - United European Gastroenterology Journal - Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG‐IBD study - Dragoni - 2023 - United European Gastroenterology Journal -](https://onlinelibrary.wiley.com/cms/asset/fa34ee68-f9f6-4d4f-ba5c-a3f91b1f5187/ueg212367-toc-0001-m.jpg)
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG‐IBD study - Dragoni - 2023 - United European Gastroenterology Journal -
![British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut](https://gut.bmj.com/content/gutjnl/68/Suppl_3/s1/F2.large.jpg)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
![Location is important: differentiation between ileal and colonic Crohn's disease | Nature Reviews Gastroenterology & Hepatology Location is important: differentiation between ileal and colonic Crohn's disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00424-6/MediaObjects/41575_2021_424_Fig1_HTML.png)
Location is important: differentiation between ileal and colonic Crohn's disease | Nature Reviews Gastroenterology & Hepatology
![Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update](https://www.frontiersin.org/files/Articles/1022530/fgstr-01-1022530-HTML-r1/image_m/fgstr-01-1022530-g001.jpg)
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
![JCM | Free Full-Text | Contemporary Management of Postoperative Crohn’s Disease after Ileocolonic Resection JCM | Free Full-Text | Contemporary Management of Postoperative Crohn’s Disease after Ileocolonic Resection](https://www.mdpi.com/jcm/jcm-11-06746/article_deploy/html/images/jcm-11-06746-g001.png)